Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice
Description
CONCLUSION: This report is among the first to describe the impact of COVID-19 on a diverse advanced HF practice. It highlights the risks associated with COVID-19 faced by the HF, LVAD and HTx patients. A 90-day mortality rate of 19 % with HTx
